Please sign in to follow a disease.
T-cell prolymphocytic leukemia
Clinical trials for T-cell prolymphocytic leukemia explained in plain language.
Never miss a new study
Get alerted when new T-cell prolymphocytic leukemia trials appear
Sign up with your email to follow new studies for T-cell prolymphocytic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered donor cells take aim at tough blood cancers in early trial
Disease control PausedThis early-phase trial tests a new type of immune cell therapy called WU-CART-007 for people with certain blood cancers, including acute myeloid leukemia and T-cell lymphoma, that have come back or not responded to treatment. The therapy uses donor cells that are genetically modi…
Matched conditions: T-CELL PROLYMPHOCYTIC LEUKEMIA
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug may make stem cell transplants safer for older patients
Disease control OngoingThis early-phase trial tests whether the drug itacitinib can prevent cytokine release syndrome (a severe inflammatory reaction) after a mini stem cell transplant in people aged 60 and older with certain blood cancers. The study also aims to see if itacitinib allows doctors to use…
Matched conditions: T-CELL PROLYMPHOCYTIC LEUKEMIA
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC